Special Counsel Jill Wright was quoted in a Modern Healthcare article, “HHS Investigators Will Prioritize Causes for High Drug Prices in 2017,” on November 11, 2016. The article discussed top issues U.S. Department of Health and Human Services Office of Inspector General (OIG) hopes to tackle in 2017, including a heightened focus on drug costs. One area the agency plans to review is whether the Centers for Medicare & Medicaid Services can save money if U.S. providers purchased smaller-size single-use drug vials that are used in other countries.
Wright said OIG might see the vial issue as a relatively simple way to curb waste for both providers and payers, and also represents a chance to bring the issue to the FDA, which approves vial sizes. She said, “It’s something that seems to be easy to do, and it might be sort of low-hanging fruit as far as preventing tax payers dollars from being wasted.”
Wright said OIG might see the vial issue as a relatively simple way to curb waste for both providers and payers, and also represents a chance to bring the issue to the FDA, which approves vial sizes. She said, “It’s something that seems to be easy to do, and it might be sort of low-hanging fruit as far as preventing tax payers dollars from being wasted.”
Related News
06 February 2025
In the News
Vanessa Miller Assesses Panama Canal Discourse
Foley & Lardner LLP partner Vanessa Miller commented in SupplyChainBrain article, "The Fight for Control of the Panama Canal," lending important context to the recent headlines over the important waterway.
06 February 2025
In the News
Gregory Husisian Weighs in on Suspension of De Minimis Trade Exemption
Foley & Lardner LLP partner Gregory Husisian offered context on President Trump's recent trade actions on China in The Wall Street Journal article, "Why Trump Is Closing a Trade Exemption for China."
04 February 2025
In the News
Andrew Wronski on Tariff Fluidity – 'Keep on top of the issues'
Foley & Lardner LLP partner Andrew Wronski assessed the evolving shift in U.S. trade policy in the Milwaukee Business Journal article, "Trump tariffs won't disappear — so how should Wisconsin businesses prepare?"